BMRI’s 1Q22 net profit jumped 69.5% to IDR 10.0 trillion. This achievement was supported by the growth of interest and non-interest income. Meanwhile, operating expenses were still manageable. Furthermore, provision expense also decreased by 25.9% YoY. NHKSI Research sees that BMRI is again focusing on high-yield assets to maintain growth in 2022.
Download full report HERE.